NO143219C - Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Info

Publication number
NO143219C
NO143219C NO763372A NO763372A NO143219C NO 143219 C NO143219 C NO 143219C NO 763372 A NO763372 A NO 763372A NO 763372 A NO763372 A NO 763372A NO 143219 C NO143219 C NO 143219C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogue procedure
relations
active relations
Prior art date
Application number
NO763372A
Other languages
English (en)
Norwegian (no)
Other versions
NO143219B (no
NO763372L (fr
Inventor
Louis Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of NO763372L publication Critical patent/NO763372L/no
Publication of NO143219B publication Critical patent/NO143219B/no
Publication of NO143219C publication Critical patent/NO143219C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electronic Switches (AREA)
NO763372A 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. NO143219C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40419/75A GB1520812A (en) 1975-10-02 1975-10-02 Benzhydrylsulphinyl derivatives

Publications (3)

Publication Number Publication Date
NO763372L NO763372L (fr) 1977-04-05
NO143219B NO143219B (no) 1980-09-22
NO143219C true NO143219C (no) 1981-01-07

Family

ID=10414819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763372A NO143219C (no) 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Country Status (29)

Country Link
US (1) US4066686A (fr)
JP (1) JPS6045186B2 (fr)
AT (1) AT347426B (fr)
AU (1) AU511619B2 (fr)
BE (1) BE846880A (fr)
CH (1) CH614934A5 (fr)
CS (1) CS200195B2 (fr)
DE (1) DE2642511C2 (fr)
DK (1) DK151009C (fr)
ES (1) ES452063A1 (fr)
FI (1) FI63220C (fr)
FR (1) FR2326181A1 (fr)
GB (1) GB1520812A (fr)
GE (1) GEP19960242B (fr)
HU (1) HU175109B (fr)
IE (1) IE43553B1 (fr)
IL (1) IL50599A (fr)
LU (1) LU75909A1 (fr)
NL (1) NL187629C (fr)
NO (1) NO143219C (fr)
NZ (1) NZ182207A (fr)
OA (1) OA05444A (fr)
PH (1) PH12533A (fr)
PL (1) PL105506B1 (fr)
PT (1) PT65648B (fr)
SE (1) SE431088B (fr)
SU (1) SU651693A3 (fr)
YU (1) YU40464B (fr)
ZA (1) ZA765830B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1106403A (fr) * 1977-04-29 1981-08-04 Victor Lafon Procede d'obtention de (3,4-dichlorophenyl-sulfinyl)- acetamidoxime et de ses sels d'addition
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2528040A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Benzhydrylsulfinylethylamines, procede de preparation et utilisation en therapeutique
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2569186B1 (fr) * 1984-08-20 1986-09-05 Lafon Labor Derives de 1-(n-(a-amino-a-methylacetyl)-aminophenyl)-2-amino-propanone, procede de preparation et utilisation en therapeutique
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
JPH02162176A (ja) * 1988-12-14 1990-06-21 Sanyo Electric Co Ltd ライトの取付装置
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5571825A (en) * 1995-03-31 1996-11-05 Warner-Lambert Company Method of selectively inhibiting prostaglandin G/H synthase-2
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
DE69823019T2 (de) * 1997-02-27 2005-03-31 Wyeth Holdings Corp. N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl, sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP1437345A1 (fr) * 2003-01-13 2004-07-14 Organisation de Synthese Mondiale Orsymonde Procédé pour la préparation de 2-diphénylméthylsulfinylacétate de méthyl
US7186860B2 (en) 2003-01-31 2007-03-06 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (fr) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited Procede pour preparer des derives de diphenylmethylsulfinyle
EP1586560A1 (fr) * 2004-04-13 2005-10-19 Cephalon, Inc. Dérivés arylméthanesulfinyles thio-substitués
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP2043623A4 (fr) * 2006-07-12 2013-03-20 Elan Pharma Int Ltd Formulations de nanoparticules de modafinil
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
USD681056S1 (en) * 2012-09-09 2013-04-30 Apple Inc. Electronic device
WO2014138518A2 (fr) 2013-03-08 2014-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibiteurs puissants et sélectifs de transporteurs de monoamine; procédé de fabrication; et leur utilisation
CN104610108B (zh) * 2015-01-27 2016-03-30 潍坊医学院 一种中枢神经系统药物阿屈非尼中间体化合物的合成方法
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2394597A (en) * 1942-07-09 1946-02-12 Eastman Kodak Co Preparation of organic dhsocyanates
NL6406688A (fr) * 1964-06-05 1965-12-06

Also Published As

Publication number Publication date
GEP19960242B (en) 1996-06-01
JPS5246058A (en) 1977-04-12
CS200195B2 (cs) 1980-08-29
DE2642511C2 (de) 1986-07-31
IE43553L (en) 1977-04-02
OA05444A (fr) 1981-03-31
FI63220C (fi) 1983-05-10
PH12533A (en) 1979-05-17
FI762810A (fr) 1977-04-03
ATA720876A (de) 1978-05-15
JPS6045186B2 (ja) 1985-10-08
PT65648A (pt) 1976-10-01
HU175109B (hu) 1980-05-28
DE2642511A1 (de) 1977-04-14
NL187629C (nl) 1991-12-02
FI63220B (fi) 1983-01-31
NL187629B (nl) 1991-07-01
IL50599A0 (en) 1976-12-31
AU1818876A (en) 1978-04-06
YU40464B (en) 1986-02-28
US4066686A (en) 1978-01-03
FR2326181B1 (fr) 1980-08-08
NO143219B (no) 1980-09-22
IL50599A (en) 1980-09-16
NO763372L (fr) 1977-04-05
SU651693A3 (ru) 1979-03-05
DK437576A (da) 1977-04-03
CH614934A5 (fr) 1979-12-28
LU75909A1 (fr) 1977-05-11
FR2326181A1 (fr) 1977-04-29
PL105506B1 (pl) 1979-10-31
DK151009B (da) 1987-10-12
ES452063A1 (es) 1977-10-01
AU511619B2 (en) 1980-08-28
ZA765830B (en) 1977-09-28
YU241476A (en) 1982-02-28
AT347426B (de) 1978-12-27
NZ182207A (en) 1978-03-06
PT65648B (fr) 1978-04-07
DK151009C (da) 1988-02-29
SE7610940L (sv) 1977-04-03
IE43553B1 (en) 1981-03-25
BE846880A (fr) 1977-04-01
GB1520812A (en) 1978-08-09
NL7610929A (nl) 1977-04-05
SE431088B (sv) 1984-01-16

Similar Documents

Publication Publication Date Title
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO144926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO144928C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO145540C (no) Fremgangsmaate for fremstilling av terapeutisk aktive polyribonukleotider